{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:51:24Z","timestamp":1793163084260,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55223-9","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:41:37Z","timestamp":1736509297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2737-4251","authenticated-orcid":false,"given":"Francesco","family":"Millozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7043-2920","authenticated-orcid":false,"given":"Paula","family":"Mil\u00e1n-Rois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-5140","authenticated-orcid":false,"given":"Arghya","family":"Sett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Delli Carpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-970X","authenticated-orcid":false,"given":"Marco","family":"De Bardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9815-0354","authenticated-orcid":false,"given":"Miguel","family":"Gisbert-Garzar\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sandon\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-2495","authenticated-orcid":false,"given":"Ciro","family":"Rodr\u00edguez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-5769","authenticated-orcid":false,"given":"Mario","family":"Mart\u00ednez-Mingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9237-7936","authenticated-orcid":false,"given":"Irene","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-4967","authenticated-orcid":false,"given":"Maria Teresa","family":"Viscomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-5360","authenticated-orcid":false,"given":"Marina","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8432-5034","authenticated-orcid":false,"given":"Jean-Jacques","family":"Toulm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-435X","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Somoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2207-2369","authenticated-orcid":false,"given":"Daniela","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"55223_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell, J. R. et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann. Neurol. 71, 304\u2013313 (2012).","journal-title":"Ann. Neurol."},{"key":"55223_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0074-7696(07)65005-0","volume":"265","author":"JM Ervasti","year":"2008","unstructured":"Ervasti, J. M. & Sonnemann, K. J. Biology of the striated muscle dystrophin-glycoprotein complex. Int Rev. Cytol. 265, 191\u2013225 (2008).","journal-title":"Int Rev. Cytol."},{"key":"55223_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","volume":"32","author":"MA Waldrop","year":"2019","unstructured":"Waldrop, M. A. & Flanigan, K. M. Update in Duchenne and Becker muscular dystrophy. Curr. Opin. Neurol. 32, 722 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"55223_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S., Mercuri, E. & Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 1\u201319 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"55223_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/hum.2022.190","volume":"34","author":"JS Chamberlain","year":"2023","unstructured":"Chamberlain, J. S. et al. Microdystrophin expression as a surrogate endpoint for Duchenne muscular dystrophy clinical trials. Hum. Gene Ther. 34, 404\u2013415 (2023).","journal-title":"Hum. Gene Ther."},{"key":"55223_CR6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013243","volume":"13","author":"SM Hammond","year":"2021","unstructured":"Hammond, S. M. et al. Delivery of oligonucleotide-based therapeutics: challenges and opportunities. EMBO Mol. Med. 13, e13243 (2021).","journal-title":"EMBO Mol. Med."},{"key":"55223_CR7","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","volume":"28","author":"JM Crudele","year":"2019","unstructured":"Crudele, J. M. & Chamberlain, J. S. AAV-based gene therapies for the muscular dystrophies. Hum. Mol. Genet 28, R102\u2013R107 (2019).","journal-title":"Hum. Mol. Genet"},{"key":"55223_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.stem.2018.03.022","volume":"22","author":"NC Chang","year":"2018","unstructured":"Chang, N. C. et al. The Dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell commitment. Cell Stem Cell 22, 755\u2013768.e6 (2018).","journal-title":"Cell Stem Cell"},{"key":"55223_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont, N. A. et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat. Med. 21, 1455\u20131463 (2015).","journal-title":"Nat. Med"},{"key":"55223_CR10","doi-asserted-by":"publisher","first-page":"1180980","DOI":"10.3389\/fphys.2023.1180980","volume":"14","author":"K Kodippili","year":"2023","unstructured":"Kodippili, K. & Rudnicki, M. A. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Front Physiol. 14, 1180980 (2023).","journal-title":"Front Physiol."},{"key":"55223_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2019.01.002","volume":"24","author":"YX Wang","year":"2019","unstructured":"Wang, Y. X. et al. EGFR-aurka signaling rescues polarity and regeneration defects in dystrophin-deficient muscle stem cells by increasing asymmetric divisions. Cell Stem Cell 24, 419\u2013432.e6 (2019).","journal-title":"Cell Stem Cell"},{"key":"55223_CR12","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco, A. et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell 143, 1059\u20131071 (2010).","journal-title":"Cell"},{"key":"55223_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1101\/gad.293266.116","volume":"31","author":"L Latella","year":"2017","unstructured":"Latella, L. et al. DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation. Genes Dev. 31, 648\u2013659 (2017).","journal-title":"Genes Dev."},{"key":"55223_CR14","doi-asserted-by":"publisher","first-page":"e135703","DOI":"10.1172\/jci.insight.135703","volume":"5","author":"DA M\u00e1zala","year":"2020","unstructured":"M\u00e1zala, D. A. et al. TGF-\u03b2-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. JCI Insight 5, e135703 (2020).","journal-title":"JCI Insight"},{"key":"55223_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41420-023-01503-0","volume":"9","author":"DAG M\u00e1zala","year":"2023","unstructured":"M\u00e1zala, D. A. G. et al. Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD. Cell Death Discov. 9, 224 (2023).","journal-title":"Cell Death Discov."},{"key":"55223_CR16","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.3390\/ijms22084236","volume":"22","author":"AE Ar\u00e1nega","year":"2021","unstructured":"Ar\u00e1nega, A. E. et al. MiRNAs and muscle regeneration: therapeutic targets in Duchenne muscular dystrophy. Int J. Mol. Sci. 22, 4236 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"55223_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"55223_CR18","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.0602831103","volume":"103","author":"PK Rao","year":"2006","unstructured":"Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S. & Lodish, H. F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl Acad. Sci. USA 103, 8721\u20138726 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"55223_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"J-F Chen","year":"2006","unstructured":"Chen, J.-F. et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet 38, 228\u2013233 (2006).","journal-title":"Nat. Genet"},{"key":"55223_CR20","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1128\/MCB.00536-15","volume":"35","author":"E Lozano-Velasco","year":"2015","unstructured":"Lozano-Velasco, E. et al. A Pitx2-microRNA pathway modulates cell proliferation in myoblasts and skeletal-muscle satellite cells and promotes their commitment to a myogenic cell fate. Mol. Cell Biol. 35, 2892\u20132909 (2015).","journal-title":"Mol. Cell Biol."},{"key":"55223_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cmet.2013.01.004","volume":"17","author":"H Yin","year":"2013","unstructured":"Yin, H. et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab. 17, 210\u2013224 (2013).","journal-title":"Cell Metab."},{"key":"55223_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.stem.2018.09.017","volume":"23","author":"MB Baghdadi","year":"2018","unstructured":"Baghdadi, M. B. et al. Notch-Induced miR-708 antagonizes satellite cell migration and maintains quiescence. Cell Stem Cell 23, 859\u2013868.e5 (2018).","journal-title":"Cell Stem Cell"},{"key":"55223_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21991-w","volume":"8","author":"D Castel","year":"2018","unstructured":"Castel, D. et al. Small-RNA sequencing identifies dynamic microRNA deregulation during skeletal muscle lineage progression. Sci. Rep. 8, 4208 (2018).","journal-title":"Sci. Rep."},{"key":"55223_CR24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902468RR","volume":"35","author":"C Mytidou","year":"2021","unstructured":"Mytidou, C. et al. Muscle-derived exosomes encapsulate myomiRs and are involved in local skeletal muscle tissue communication. FASEB J. 35, e21279 (2021).","journal-title":"FASEB J."},{"key":"55223_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050863","volume":"21","author":"M Sandon\u00e0","year":"2020","unstructured":"Sandon\u00e0, M. et al. HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle-resident mesenchymal cells. EMBO Rep. 21, e50863 (2020).","journal-title":"EMBO Rep."},{"key":"55223_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1101\/gad.234468.113","volume":"28","author":"V Saccone","year":"2014","unstructured":"Saccone, V. et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev. 28, 841\u2013857 (2014).","journal-title":"Genes Dev."},{"key":"55223_CR27","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1172\/JCI62656","volume":"122","author":"N Liu","year":"2012","unstructured":"Liu, N. et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054\u20132065 (2012).","journal-title":"J. Clin. Invest."},{"key":"55223_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2013.00011","volume":"19","author":"S Consalvi","year":"2013","unstructured":"Consalvi, S. et al. Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol. Med. 19, 79\u201387 (2013).","journal-title":"Mol. Med."},{"key":"55223_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/emmm.201202096","volume":"5","author":"C Mozzetta","year":"2013","unstructured":"Mozzetta, C. et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol. Med. 5, 626\u2013639 (2013).","journal-title":"EMBO Mol. Med."},{"key":"55223_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti, G. C. et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12, 1147\u20131150 (2006).","journal-title":"Nat. Med"},{"key":"55223_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","volume":"23","author":"E Mercuri","year":"2024","unstructured":"Mercuri, E. et al. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 23, 393\u2013403 (2024).","journal-title":"Lancet Neurol."},{"key":"55223_CR32","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1039\/C4NR00019F","volume":"6","author":"A Latorre","year":"2014","unstructured":"Latorre, A. et al. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Nanoscale 6, 7436\u20137442 (2014).","journal-title":"Nanoscale"},{"key":"55223_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s13346-022-01232-4","volume":"13","author":"R Zhang","year":"2023","unstructured":"Zhang, R., Kiessling, F., Lammers, T. & Pallares, R. M. Clinical translation of gold nanoparticles. Drug Deliv. Transl. Res. 13, 378\u2013385 (2023).","journal-title":"Drug Deliv. Transl. Res."},{"key":"55223_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/nnm.13.204","volume":"9","author":"HY Xue","year":"2014","unstructured":"Xue, H. Y., Liu, S. & Wong, H. L. Nanotoxicity: A key obstacle to clinical translation of siRNA-based. Nanomed. Nanomed. 9, 295\u2013312 (2014).","journal-title":"Nanomed. Nanomed."},{"key":"55223_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gad.257394.114","volume":"29","author":"FM Kouri","year":"2015","unstructured":"Kouri, F. M. et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 29, 732\u2013745 (2015).","journal-title":"Genes Dev."},{"key":"55223_CR36","doi-asserted-by":"publisher","first-page":"209ra152","DOI":"10.1126\/scitranslmed.3006839","volume":"5","author":"SA Jensen","year":"2013","unstructured":"Jensen, S. A. et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 5, 209ra152 (2013).","journal-title":"Sci. Transl. Med"},{"key":"55223_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-0716-2010-6_6","volume":"2434","author":"P Mil\u00e1n-Rois","year":"2022","unstructured":"Mil\u00e1n-Rois, P., Rodriguez-Diaz, C., Castellanos, M. & Somoza, \u00c1. Conjugation of nucleic acids and drugs to gold nanoparticles. Methods Mol. Biol. 2434, 103\u2013116 (2022).","journal-title":"Methods Mol. Biol."},{"key":"55223_CR38","doi-asserted-by":"crossref","unstructured":"Cutler, J. I., Auyeung, E. & Mirkin, C. A. Spherical Nucleic Acids. Vol. 4 (Jenny Stanford, 2020).","DOI":"10.1201\/9781003056676-5"},{"key":"55223_CR39","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.molmed.2019.08.012","volume":"25","author":"A Mokhtarzadeh","year":"2019","unstructured":"Mokhtarzadeh, A. et al. Applications of spherical nucleic acid nanoparticles as delivery systems. Trends Mol. Med 25, 1066\u20131079 (2019).","journal-title":"Trends Mol. Med"},{"key":"55223_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9440(10)62249-3","volume":"166","author":"DJ Burkin","year":"2005","unstructured":"Burkin, D. J. et al. Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am. J. Pathol. 166, 253\u2013263 (2005).","journal-title":"Am. J. Pathol."},{"key":"55223_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.152.6.1207","volume":"152","author":"DJ Burkin","year":"2001","unstructured":"Burkin, D. J., Wallace, G. Q., Nicol, K. J., Kaufman, D. J. & Kaufman, S. J. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol. 152, 1207\u20131218 (2001).","journal-title":"J. Cell Biol."},{"key":"55223_CR42","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.3390\/molecules25153489","volume":"25","author":"D Ferreira","year":"2020","unstructured":"Ferreira, D. et al. Gold nanoparticles for vectorization of nucleic acids for cancer therapeutics. Molecules 25, 3489 (2020).","journal-title":"Molecules"},{"key":"55223_CR43","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.3390\/cancers14215366","volume":"14","author":"GA Kanu","year":"2022","unstructured":"Kanu, G. A., Parambath, J. B. M., Abu Odeh, R. O. & Mohamed, A. A. Gold nanoparticle-mediated gene therapy. Cancers 14, 5366 (2022).","journal-title":"Cancers"},{"key":"55223_CR44","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1039\/C9TB02924A","volume":"8","author":"W Wang","year":"2020","unstructured":"Wang, W., Wang, J. & Ding, Y. Gold nanoparticle-conjugated nanomedicine: design, construction, and structure\u2013efficacy relationship studies. J. Mater. Chem. B 8, 4813\u20134830 (2020).","journal-title":"J. Mater. Chem. B"},{"key":"55223_CR45","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1039\/D0AN00634C","volume":"145","author":"T Fellows","year":"2020","unstructured":"Fellows, T. et al. Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX. Analyst 145, 5180\u20135193 (2020).","journal-title":"Analyst"},{"key":"55223_CR46","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1172\/JCI119716","volume":"100","author":"PH Vachon","year":"1997","unstructured":"Vachon, P. H. et al. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100, 1870\u20131881 (1997).","journal-title":"J. Clin. Invest."},{"key":"55223_CR47","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ymthe.2017.03.022","volume":"25","author":"A Sarathy","year":"2017","unstructured":"Sarathy, A. et al. SU9516 increases \u03b17\u03b21 integrin and ameliorates disease progression in the mdx mouse model of Duchenne muscular dystrophy. Mol. Ther. 25, 1395\u20131407 (2017).","journal-title":"Mol. Ther."},{"key":"55223_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55223_CR49","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/ijms24021175","volume":"24","author":"F Millozzi","year":"2023","unstructured":"Millozzi, F., Papait, A., Bouch\u00e9, M., Parolini, O. & Palacios, D. Nano-immunomodulation: a new strategy for skeletal muscle diseases and aging? Int J. Mol. Sci. 24, 1175 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"55223_CR50","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer, S. et al. rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotech. 8, 772\u2013781 (2013).","journal-title":"Nat. Nanotech."},{"key":"55223_CR51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","volume":"14","author":"VP Vu","year":"2019","unstructured":"Vu, V. P. et al. Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles. Nat. Nanotechnol. 14, 260\u2013268 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"55223_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biomaterials.2018.05.027","volume":"175","author":"J Ge","year":"2018","unstructured":"Ge, J. et al. Gold and gold-silver alloy nanoparticles enhance the myogenic differentiation of myoblasts through p38 MAPK signaling pathway and promote in vivo skeletal muscle regeneration. Biomaterials 175, 19\u201329 (2018).","journal-title":"Biomaterials"},{"key":"55223_CR53","doi-asserted-by":"crossref","unstructured":"Colapicchioni, V., Millozzi, F., Parolini, O. & Palacios, D. Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 14, e1777 (2022).","DOI":"10.1002\/wnan.1777"},{"key":"55223_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2015.00036","volume":"7","author":"A Brancaccio","year":"2015","unstructured":"Brancaccio, A. & Palacios, D. Chromatin signaling in muscle stem cells: interpreting the regenerative microenvironment. Front. Aging Neurosci. 7, 36 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"55223_CR55","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1083\/jcb.200911036","volume":"190","author":"J-F Chen","year":"2010","unstructured":"Chen, J.-F. et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 190, 867\u2013879 (2010).","journal-title":"J. Cell Biol."},{"key":"55223_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104444","volume":"25","author":"AA Cutler","year":"2022","unstructured":"Cutler, A. A. et al. The regenerating skeletal muscle niche drives satellite cell return to quiescence. iScience 25, 104444 (2022).","journal-title":"iScience"},{"key":"55223_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","volume":"87","author":"RS Geary","year":"2015","unstructured":"Geary, R. S., Norris, D., Yu, R. & Bennett, C. F. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv. Drug Deliv. Rev. 87, 46\u201351 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"55223_CR58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1021\/acs.bioconjchem.9b00707","volume":"31","author":"B Du","year":"2020","unstructured":"Du, B. et al. Tailoring kidney transport of organic dyes with low-molecular-weight PEGylation. Bioconjugate Chem. 31, 241\u2013247 (2020).","journal-title":"Bioconjugate Chem."},{"key":"55223_CR59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1364\/BOE.417321","volume":"12","author":"D Katoozi","year":"2021","unstructured":"Katoozi, D., Clayton, A. H. A., Moss, D. J. & Chon, J. W. M. Uptake quantification of gold nanoparticles inside of cancer cells using high order image correlation spectroscopy. Biomed. Opt. Express 12, 539\u2013552 (2021).","journal-title":"Biomed. Opt. Express"},{"key":"55223_CR60","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673\u2013694 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55223_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01994-0","volume":"21","author":"MR Hicks","year":"2023","unstructured":"Hicks, M. R. et al. Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD. J. Nanobiotechnol. 21, 303 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"55223_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-60761-609-2_20","volume":"624","author":"M Rothdiener","year":"2010","unstructured":"Rothdiener, M., Beuttler, J., Messerschmidt, S. K. E. & Kontermann, R. E. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes. Methods Mol. Biol. 624, 295\u2013308 (2010).","journal-title":"Methods Mol. Biol."},{"key":"55223_CR63","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.biomaterials.2011.11.036","volume":"33","author":"C-H Wang","year":"2012","unstructured":"Wang, C.-H. et al. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 33, 1939\u20131947 (2012).","journal-title":"Biomaterials"},{"key":"55223_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nano.2013.07.015","volume":"10","author":"S Acharya","year":"2014","unstructured":"Acharya, S. & Hill, R. A. High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes. Nanomedicine 10, 329\u2013337 (2014).","journal-title":"Nanomedicine"},{"key":"55223_CR65","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1021\/acs.molpharmaceut.8b01313","volume":"16","author":"SD Jativa","year":"2019","unstructured":"Jativa, S. D. et al. Enhanced delivery of plasmid DNA to skeletal muscle cells using a DLC8-binding peptide and ASSLNIA-modified PAMAM dendrimer. Mol. Pharm. 16, 2376\u20132384 (2019).","journal-title":"Mol. Pharm."},{"key":"55223_CR66","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1039\/C7PY00568G","volume":"8","author":"JL Ungerleider","year":"2017","unstructured":"Ungerleider, J. L., Kammeyer, J. K., Braden, R. L., Christman, K. L. & Gianneschi, N. C. Enzyme-targeted nanoparticles for delivery to ischemic skeletal muscle. Polym. Chem. 8, 5212\u20135219 (2017).","journal-title":"Polym. Chem."},{"key":"55223_CR67","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1093\/nar\/gkad415","volume":"51","author":"B Malecova","year":"2023","unstructured":"Malecova, B. et al. Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs). Nucleic Acids Res. 51, 5901\u20135910 (2023).","journal-title":"Nucleic Acids Res."},{"key":"55223_CR68","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","volume":"186","author":"SM Hindi","year":"2023","unstructured":"Hindi, S. M. et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell 186, 2062\u20132077.e17 (2023).","journal-title":"Cell"},{"key":"55223_CR69","doi-asserted-by":"publisher","first-page":"13446","DOI":"10.18632\/oncotarget.7178","volume":"7","author":"G Zhou","year":"2016","unstructured":"Zhou, G. et al. Aptamers: A promising chemical antibody for cancer therapy. Oncotarget 7, 13446\u201313463 (2016).","journal-title":"Oncotarget"},{"key":"55223_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.omtn.2017.12.004","volume":"10","author":"S Philippou","year":"2018","unstructured":"Philippou, S. et al. Selection and identification of skeletal-muscle-targeted RNA aptamers. Mol. Ther. Nucleic Acids 10, 199\u2013214 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"55223_CR71","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.stem.2016.09.010","volume":"20","author":"CS Fry","year":"2017","unstructured":"Fry, C. S., Kirby, T. J., Kosmac, K., McCarthy, J. J. & Peterson, C. A. Myogenic progenitor cells control extracellular matrix production by fibroblasts during skeletal muscle hypertrophy. Cell Stem Cell 20, 56\u201369 (2017).","journal-title":"Cell Stem Cell"},{"key":"55223_CR72","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.2174\/1568026614666141215143659","volume":"14","author":"A Latorre","year":"2014","unstructured":"Latorre, A. & Somoza, \u00c1. Glutathione-triggered drug release from nanostructures. Curr. Top. Med Chem. 14, 2662\u20132671 (2014).","journal-title":"Curr. Top. Med Chem."},{"key":"55223_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/736837","volume":"2012","author":"VI Lushchak","year":"2012","unstructured":"Lushchak, V. I. Glutathione homeostasis and functions: potential targets for medical interventions. J. Amino Acids 2012, 736837 (2012).","journal-title":"J. Amino Acids"},{"key":"55223_CR74","doi-asserted-by":"publisher","first-page":"17205","DOI":"10.1016\/S0021-9258(19)77815-6","volume":"263","author":"A Meister","year":"1988","unstructured":"Meister, A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263, 17205\u201317208 (1988).","journal-title":"J. Biol. Chem."},{"key":"55223_CR75","doi-asserted-by":"crossref","unstructured":"Sen, C. K. Glutathione: A key role in skeletal muscle metabolism. In Oxidative Stress in Skeletal Muscle (eds. Reznick, A. Z., Packer, L., Sen, C. K., Holloszy, J. O. & Jackson, M. J.) 127\u2013139 (Birkh\u00e4user, Basel, 1998).","DOI":"10.1007\/978-3-0348-8958-2_8"},{"key":"55223_CR76","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1021\/ac0613582","volume":"78","author":"SJ Hurst","year":"2006","unstructured":"Hurst, S. J., Lytton-Jean, A. K. R. & Mirkin, C. A. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem. 78, 8313\u20138318 (2006).","journal-title":"Anal. Chem."},{"key":"55223_CR77","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.3390\/ma15093355","volume":"15","author":"J Milan","year":"2022","unstructured":"Milan, J., Niemczyk, K. & Kus-Li\u015bkiewicz, M. Treasure on the earth-gold nanoparticles and their biomedical applications. Materials 15, 3355 (2022).","journal-title":"Materials"},{"key":"55223_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-021-03632-w","volume":"16","author":"NRS Sibuyi","year":"2021","unstructured":"Sibuyi, N. R. S. et al. Multifunctional gold nanoparticles for improved diagnostic and therapeutic applications: a review. Nanoscale Res Lett. 16, 174 (2021).","journal-title":"Nanoscale Res Lett."},{"key":"55223_CR79","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"55223_CR80","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1021\/nn9003814","volume":"3","author":"AE Prigodich","year":"2009","unstructured":"Prigodich, A. E. et al. Nano-flares for mRNA regulation and detection. ACS Nano 3, 2147\u20132152 (2009).","journal-title":"ACS Nano"},{"key":"55223_CR81","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.3390\/biomimetics3040028","volume":"3","author":"P Mil\u00e1n Rois","year":"2018","unstructured":"Mil\u00e1n Rois, P., Latorre, A., Rodriguez Diaz, C., Del Moral, \u00c1. & Somoza, \u00c1. Reprogramming cells for synergistic combination therapy with nanotherapeutics against uveal melanoma. Biomim. (Basel) 3, E28 (2018).","journal-title":"Biomim. (Basel)"},{"key":"55223_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103984","volume":"230","author":"S Ciordia","year":"2021","unstructured":"Ciordia, S. et al. Digging deeper into bile proteome. J. Proteom. 230, 103984 (2021).","journal-title":"J. Proteom."},{"key":"55223_CR83","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55223-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T13:06:14Z","timestamp":1736514374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55223-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55223"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55223-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application has been filed by the Universit\u00e0 Cattolica del Sacro Cuore, IMDEA Nanociencias, Inserm and IRCCS Fondazione Santa Lucia with D.P. A.So., J.-J.T., F.M., P.M.-R and A.S. as inventors (Nucleic acid aptamers recognizing the extra cellular domain of alpha7\/beta1 integrin dimers and uses thereof. Application number: 102024000007594.). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"577"}}